Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
21,246,669
-
Share change
-
+2,090,862
-
Total reported value
-
$712,189,095
-
Price per share
-
$33.52
-
Number of holders
-
117
-
Value change
-
+$88,173,279
-
Number of buys
-
87
-
Number of sells
-
26
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2019
As of 30 Sep 2019 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,246,669 shares of stock of the company.
Largest 10 holders included FMR LLC, CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, Polaris Venture Management Co. V, L.L.C., BlackRock Inc., VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, Antipodean Advisors LLC, and Grantham, Mayo, Van Otterloo & Co. LLC.
This table shows 117 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.